Related Experiment Video
Updated: Aug 1, 2025
06:52
Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
9.9K
Medication-Related Complaints in Residential Aged Care
Juanita L Breen1,2, Kathleen V Williams1, Melanie J Wroth3
1Clinical Pharmacy Unit, Aged Care Quality and Safety Commission, Canberra, ACT 2601, Australia.
Pharmacy (Basel, Switzerland)
|April 27, 2023
Summary
Medication administration errors are a significant concern in Australian aged care, with most complaints focusing on timing, system failures, and chemical restraint. Residents are less likely to complain about medication issues.
Area of Science:
- Aged Care Quality and Safety
- Medication Management Systems
- Healthcare Consumer Feedback
Background:
- Complaints data offers critical insights into consumer experiences and identifies systemic issues in aged care.
- Understanding patient and family concerns is vital for improving care standards and addressing priorities.
- Medication management is a complex area within aged care, prone to errors and requiring careful oversight.
Purpose of the Study:
- To analyze and categorize medication management complaints within Australian residential aged care services.
- To identify the most frequent issues and trends in medication-related complaints.
- To provide data-driven insights for enhancing medication safety and quality in aged care.
Main Methods:
- Content analysis of 1134 medication-related complaint issues from Australian residential aged care (July 2019 - June 2020).
- Utilized a dedicated coding framework to categorize complaint issues related to medication use.
- Compared medication complaint data composition with overall complaint data.
Main Results:
- 45% of medication complaints concerned medicine administration processes.
- Top complaint categories included incorrect medication timing, inadequate management systems, and chemical restraint.
- Common indications for medication use cited in complaints were pain management, sedation, and infection control.
Conclusions:
- Medication administration timing, system deficiencies, and chemical restraint are key areas of concern in aged care medication management.
- Opioids, psychotropics, and insulin were the most frequently mentioned medication classes in complaints.
- Anonymous complaints were more prevalent for medication issues, and residents lodged fewer complaints, suggesting a need for improved engagement and reporting mechanisms.
Keywords:
chemical restraintcomplaintslong-term aged caremedicationmedication safetymedicinenursing homeopioidsprescribing regulationspsychotropicMore Related Videos
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
6.8K
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
30.6K
Related Concept Videos
01:22Alzheimer's Disease: Treatment
230
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
230
01:28Drug Therapy
76
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
76
01:29Documentation in Long-Term and Home Healthcare Setting
946
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
946
01:19Pharmacovigilance
926
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
926
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
206
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
206